BRANDY PELPHREY: Open Payments
NPI 1104300946 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 20 payments from 8 companies in 2025. Trend: 2023 $219 · 2024 $198 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $203 |
| Lilly USA, LLC | 6 | $91 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Exact Sciences Corporation | 2 | $28 |
| ABIOMED | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
Products named: EVENITY, JARDIANCE, MOUNJARO, GEMTESA, TRELEGY ELLIPTA, Cologuard Collection Kit, Ozempic.
Industry payments across KY — which companies pay providers there.
